| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 18 | - | - | - | - | - | 5 | - | - | 24 |
| - | - | - | - | - | 2 | 1 | - | - | - | 3 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 967 |
| 463 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 2 |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AME(R) | 967 | 90.8% | -1.06 | 463 | 96.1% |
| Optic-unspecified(R) | 72 | 6.8% | -2.17 | 16 | 3.3% |
| ME(R) | 24 | 2.3% | -3.00 | 3 | 0.6% |
| CentralBrain-unspecified | 2 | 0.2% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns aMe6b | % In | CV |
|---|---|---|---|---|---|
| HBeyelet (R) | 3 | HA | 311 | 29.5% | 0.1 |
| aMe6c (R) | 1 | Glu | 267 | 25.4% | 0.0 |
| aMe1 (R) | 2 | GABA | 105 | 10.0% | 0.1 |
| aMe5 (R) | 12 | ACh | 99 | 9.4% | 0.9 |
| MeVPMe12 (L) | 2 | ACh | 56 | 5.3% | 0.6 |
| MeVCMe1 (R) | 2 | ACh | 45 | 4.3% | 0.0 |
| OA-AL2i3 (R) | 2 | OA | 35 | 3.3% | 0.3 |
| MeVCMe1 (L) | 2 | ACh | 30 | 2.8% | 0.0 |
| aMe10 (L) | 1 | ACh | 10 | 0.9% | 0.0 |
| aMe6a (R) | 1 | ACh | 9 | 0.9% | 0.0 |
| aMe23 (R) | 1 | Glu | 7 | 0.7% | 0.0 |
| Mi1 (R) | 2 | ACh | 6 | 0.6% | 0.7 |
| aMe10 (R) | 2 | ACh | 6 | 0.6% | 0.7 |
| Dm9 (R) | 1 | Glu | 5 | 0.5% | 0.0 |
| Dm10 (R) | 3 | GABA | 5 | 0.5% | 0.3 |
| LoVC23 (L) | 1 | GABA | 4 | 0.4% | 0.0 |
| aMe22 (R) | 1 | Glu | 4 | 0.4% | 0.0 |
| aMe2 (R) | 2 | Glu | 4 | 0.4% | 0.5 |
| aMe4 (R) | 4 | ACh | 4 | 0.4% | 0.0 |
| aMe15 (R) | 1 | ACh | 3 | 0.3% | 0.0 |
| aMe_TBD1 (R) | 1 | GABA | 3 | 0.3% | 0.0 |
| MeVP11 (R) | 2 | ACh | 3 | 0.3% | 0.3 |
| SLP249 (R) | 2 | Glu | 3 | 0.3% | 0.3 |
| aMe30 (R) | 2 | Glu | 3 | 0.3% | 0.3 |
| Lat3 (R) | 1 | unc | 2 | 0.2% | 0.0 |
| C2 (R) | 1 | GABA | 2 | 0.2% | 0.0 |
| MeLo6 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| Lat1 (R) | 1 | unc | 2 | 0.2% | 0.0 |
| l-LNv (L) | 1 | unc | 2 | 0.2% | 0.0 |
| MeVPaMe1 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| Cm35 (R) | 1 | GABA | 2 | 0.2% | 0.0 |
| Mi15 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeLo7 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe9 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm23 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Lat2 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| s-LNv (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVPaMe2 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Cm25 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP59 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVC21 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| PLP211 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| MeVPMe13 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns aMe6b | % Out | CV |
|---|---|---|---|---|---|
| aMe4 (R) | 9 | ACh | 426 | 25.3% | 0.2 |
| aMe1 (R) | 2 | GABA | 191 | 11.4% | 0.2 |
| aMe5 (R) | 14 | ACh | 92 | 5.5% | 1.0 |
| aMe10 (R) | 2 | ACh | 81 | 4.8% | 0.5 |
| aMe17b (R) | 2 | GABA | 78 | 4.6% | 0.2 |
| MeVPMe12 (R) | 2 | ACh | 77 | 4.6% | 0.2 |
| aMe15 (R) | 1 | ACh | 75 | 4.5% | 0.0 |
| MeVPMe12 (L) | 2 | ACh | 66 | 3.9% | 0.3 |
| l-LNv (R) | 4 | unc | 64 | 3.8% | 0.6 |
| MeVPaMe2 (R) | 1 | Glu | 55 | 3.3% | 0.0 |
| Lat2 (R) | 2 | unc | 52 | 3.1% | 0.2 |
| aMe6c (R) | 1 | Glu | 49 | 2.9% | 0.0 |
| MeVP29 (R) | 1 | ACh | 37 | 2.2% | 0.0 |
| aMe3 (R) | 1 | Glu | 32 | 1.9% | 0.0 |
| aMe_TBD1 (R) | 1 | GABA | 31 | 1.8% | 0.0 |
| aMe30 (R) | 2 | Glu | 27 | 1.6% | 0.3 |
| OA-AL2i3 (R) | 2 | OA | 27 | 1.6% | 0.3 |
| SLP250 (R) | 1 | Glu | 17 | 1.0% | 0.0 |
| Cm35 (R) | 1 | GABA | 16 | 1.0% | 0.0 |
| 5thsLNv_LNd6 (R) | 2 | ACh | 15 | 0.9% | 0.2 |
| aMe13 (R) | 1 | ACh | 11 | 0.7% | 0.0 |
| Mi18 (R) | 2 | GABA | 11 | 0.7% | 0.6 |
| Lawf1 (R) | 3 | ACh | 9 | 0.5% | 0.9 |
| Lat1 (R) | 4 | unc | 9 | 0.5% | 0.7 |
| SLP249 (R) | 2 | Glu | 9 | 0.5% | 0.1 |
| s-LNv (R) | 3 | ACh | 8 | 0.5% | 0.5 |
| aMe23 (R) | 1 | Glu | 7 | 0.4% | 0.0 |
| MeVPaMe1 (R) | 1 | ACh | 7 | 0.4% | 0.0 |
| aMe26 (R) | 3 | ACh | 7 | 0.4% | 0.2 |
| MeVC21 (R) | 3 | Glu | 7 | 0.4% | 0.4 |
| LoVP53 (R) | 1 | ACh | 6 | 0.4% | 0.0 |
| CL125 (R) | 2 | Glu | 6 | 0.4% | 0.3 |
| aMe17c (R) | 2 | Glu | 5 | 0.3% | 0.6 |
| aMe2 (R) | 3 | Glu | 5 | 0.3% | 0.3 |
| aMe6a (R) | 1 | ACh | 4 | 0.2% | 0.0 |
| MeVPMe13 (R) | 1 | ACh | 4 | 0.2% | 0.0 |
| HBeyelet (R) | 3 | HA | 4 | 0.2% | 0.4 |
| C2 (R) | 2 | GABA | 3 | 0.2% | 0.3 |
| MeVC20 (R) | 2 | Glu | 3 | 0.2% | 0.3 |
| Lat3 (R) | 1 | unc | 2 | 0.1% | 0.0 |
| MeLo6 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| Cm11d (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP31 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| Lat5 (R) | 1 | unc | 2 | 0.1% | 0.0 |
| aMe22 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| aMe12 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP59 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP51 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| DNp27 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP8 (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| MeVC22 (R) | 2 | Glu | 2 | 0.1% | 0.0 |
| Dm2 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Tm5a (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Tm20 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm1 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm9 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Mi10 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Tm38 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP1 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP7 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVC_unclear (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| SMP200 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| DNpe053 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP63 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVPaMe2 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVC24 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe20 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm30 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVPaMe1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP49 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVC23 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| OA-AL2i4 (R) | 1 | OA | 1 | 0.1% | 0.0 |
| aMe17e (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| DNpe053 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVCMe1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |